Abstract

Background Esophageal cancer is one of the most deadly malignant tumors. Among the common malignant tumors in the world, esophageal cancer is ranked seventh, which has a high mortality rate. Long noncoding RNAs (lncRNAs) play an important role in the occurrence and development of various tumors. lncRNAs can competitively bind microRNAs (miRNAs) with mRNA, which can regulate the expression level of the encoded gene at the posttranscriptional level. This regulatory mechanism is called the competitive endogenous RNA (ceRNA) hypothesis, and ceRNA has important research value in tumor-related research. However, the regulation of lncRNAs is less studied in the study of esophageal cancer. Methods The Cancer Genome Atlas (TCGA) database was used to download transcriptome profiling data of esophageal cancer. Gene expression quantification data contains 160 cancer samples and 11 normal samples. These data were used to identify differentially expressed lncRNAs and mRNAs. miRNA expression data includes 185 cancer samples and 13 normal samples. The differentially expressed RNAs were identified using the edgeR package in R software. Then, the miRcode database was used to predict miRNAs that bind to lncRNAs. MiRTarBase, miRDB, and TargetScan databases were used to predict the target genes of miRNAs. Cytoscape software was used to draw ceRNA network. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed using DAVID 6.8. Finally, multifactor cox regression was used to screen lncRNAs related to prognosis. Results We have screened 1331 DElncRNAs, 3193 DEmRNAs, and 162 DEmiRNAs. Among them, the ceRNA network contains 111 lncRNAs, 11 miRNAs, and 63 DEmRNAs. Finally, we established a prediction model containing three lncRNAs through multifactor Cox regression analysis. Conclusions Our research screened out three independent prognostic lncRNAs from the ceRNA network and constructed a risk assessment model. This is helpful to understand the regulatory role of lncRNAs in esophageal cancer.

Highlights

  • Esophageal cancer (EC) is one of the most deadly malignant tumors

  • The differentially expressed RNAs were identified by using the edgeR package in R software. ∣log2 fold change ðFCÞ ∣ >1 and false discovery rate ðFDRÞ < 0:05 were the screening condition for differential RNAs. 1331 DElncRNAs (648 downregulated and 683 upregulated) and 3193 DEmRNAs (1753 downregulated and 1440 upregulated) were screened out of 160 EC samples and 11 normal samples

  • The area under the curve for 3-year survival rate was 0.639, and the area under the curve for 5-year survival rate was 0.685. These results indicated that the PI of Long noncoding RNAs (lncRNAs) showed a good prognostic ability, which suggested that the prognostic model constructed by the three lncRNAs may be a prognostic factor for EC

Read more

Summary

Introduction

Esophageal cancer (EC) is one of the most deadly malignant tumors. Among the common malignant tumors in the world, EC is ranked seventh, which has a high mortality rate [1]. Among the common malignant tumors in the world, esophageal cancer is ranked seventh, which has a high mortality rate. LncRNAs can competitively bind microRNAs (miRNAs) with mRNA, which can regulate the expression level of the encoded gene at the posttranscriptional level. This regulatory mechanism is called the competitive endogenous RNA (ceRNA) hypothesis, and ceRNA has important research value in tumor-related research. Our research screened out three independent prognostic lncRNAs from the ceRNA network and constructed a risk assessment model. This is helpful to understand the regulatory role of lncRNAs in esophageal cancer

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call